Fate Therapeutics Stock Price Prediction
| FATE Stock | USD 3.68 0.23 6.67% |
Oversold Vs Overbought
32
Oversold | Overbought |
Fate Therapeutics stock price prediction is an act of determining the future value of Fate Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Fate Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Fate Therapeutics and does not consider all of the tangible or intangible factors available from Fate Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Fate Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Fate Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.50) | EPS Estimate Current Year (1.91) | EPS Estimate Next Year (1.86) | Wall Street Target Price 6.8 | EPS Estimate Current Quarter (0.49) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Fate Therapeutics based on different types of headlines from major news networks to social media. The Fate stock price prediction module provides an analysis of price elasticity to changes in media outlook on Fate Therapeutics over a specific investment horizon. Using Fate Therapeutics hype-based prediction, you can estimate the value of Fate Therapeutics from the perspective of Fate Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Fate Therapeutics using Fate Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Fate using crowd psychology based on the activity and movement of Fate Therapeutics' stock price.
Fate Therapeutics Short Interest
A significant increase or decrease in Fate Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Fate. Short interest can provide insight into the potential direction of Fate Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long Fate Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Fate Therapeutics and may potentially protect profits, hedge Fate Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 4.0601 | Short Percent 0.2098 | Short Ratio 6.94 | Shares Short Prior Month 22.1 M | 50 Day MA 4.9816 |
Fate Therapeutics Hype to Price Pattern
Investor biases related to Fate Therapeutics' public news can be used to forecast risks associated with an investment in Fate. The trend in average sentiment can be used to explain how an investor holding Fate can time the market purely based on public headlines and social activities around Fate Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Fate Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Fate Therapeutics.
Fate Therapeutics Implied Volatility | 0.0 |
Fate Therapeutics' implied volatility exposes the market's sentiment of Fate Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Fate Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Fate Therapeutics stock will not fluctuate a lot when Fate Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Fate Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Fate Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Fate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Fate Therapeutics after-hype prediction price | USD 3.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Fate |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fate Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Fate Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Fate Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Fate Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Fate Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Fate Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Fate Therapeutics' historical news coverage. Fate Therapeutics' after-hype downside and upside margins for the prediction period are 0.19 and 8.34, respectively. We have considered Fate Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Fate Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of Fate Therapeutics is based on 3 months time horizon.
Fate Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Fate Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fate Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Fate Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.90 | 4.54 | 0.12 | 0.12 | 8 Events / Month | 12 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.68 | 3.80 | 3.26 |
|
Fate Therapeutics Hype Timeline
Fate Therapeutics is currently traded for 3.68. The entity has historical hype elasticity of 0.12, and average elasticity to hype of competition of -0.12. Fate is anticipated to increase in value after the next headline, with the price projected to jump to 3.8 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 3.26%, whereas the daily expected return is currently at -0.9%. The volatility of related hype on Fate Therapeutics is about 3492.31%, with the expected price after the next announcement by competition of 3.56. The company currently holds 103.54 M in liabilities with Debt to Equity (D/E) ratio of 0.19, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Fate Therapeutics Basic Forecasting Models to cross-verify your projections.Fate Therapeutics Related Hype Analysis
Having access to credible news sources related to Fate Therapeutics' direct competition is more important than ever and may enhance your ability to predict Fate Therapeutics' future price movements. Getting to know how Fate Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Fate Therapeutics may potentially react to the hype associated with one of its peers.
Fate Therapeutics Additional Predictive Modules
Most predictive techniques to examine Fate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Fate using various technical indicators. When you analyze Fate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Fate Therapeutics Predictive Indicators
The successful prediction of Fate Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Fate Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Fate Therapeutics based on analysis of Fate Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Fate Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Fate Therapeutics's related companies. | 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.68 | 3.87 | 3.68 | Days Of Inventory On Hand | 2.7E-5 | 2.4E-5 | 1.2E-5 |
Story Coverage note for Fate Therapeutics
The number of cover stories for Fate Therapeutics depends on current market conditions and Fate Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Fate Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Fate Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Fate Therapeutics Short Properties
Fate Therapeutics' future price predictability will typically decrease when Fate Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Fate Therapeutics often depends not only on the future outlook of the potential Fate Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fate Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 98.4 M | |
| Cash And Short Term Investments | 315.2 M |
Check out Fate Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Fate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 0.065 | Quarterly Revenue Growth (0.97) | Return On Assets (0.21) | Return On Equity (0.42) |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.